• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.

作者信息

Burger D, Schleuning W D, Schapira M

出版信息

J Biol Chem. 1986 Jan 5;261(1):324-7.

PMID:2416749
Abstract

Prekallikrein was purified from human plasma with a final yield of 76% using as the principal step adsorption to immobilized chicken antikallikrein IgY. When purified prekallikrein (3.4 microM) was incubated in the presence of beta-Factor XIIa (0.068 microM) for 5 min at 37 degrees C and pH 7.5, alpha-kallikrein was obtained. Upon prolonged incubation (0.5-28 h), the Mr 52,000 heavy chain of alpha-kallikrein was progressively cleaved, resulting in the formation of beta-kallikrein. The formation of beta-kallikrein was characterized as an autolytic process because it was prevented by specific inhibitors of kallikrein, including aprotinin and antikallikrein antibody but not by corn trypsin inhibitor, an inhibitor specific for beta-Factor XIIa.

摘要

相似文献

1
Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.
J Biol Chem. 1986 Jan 5;261(1):324-7.
2
Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.表面介导的牛因子XII和前激肽释放酶激活机制。
Adv Exp Med Biol. 1983;156:87-107.
3
Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.人血浆激肽释放酶诱导的人高分子量激肽原的辅因子功能降低或不变。
Adv Exp Med Biol. 1986;198 Pt A:147-53. doi: 10.1007/978-1-4684-5143-6_20.
4
Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.豚鼠血浆前激肽释放酶的纯化。源自豚鼠皮肤的前激肽释放酶激活剂对其的激活作用。
Biochim Biophys Acta. 1980 Aug 7;614(2):511-25. doi: 10.1016/0005-2744(80)90240-5.
5
Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.表面介导的牛因子XII和前激肽释放酶激活的动力学研究。高岭土和高分子量激肽原对激活反应的影响。
Eur J Biochem. 1985 Jan 2;146(1):43-50. doi: 10.1111/j.1432-1033.1985.tb08617.x.
6
A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
Blood. 1987 Oct;70(4):1053-62.
7
Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.人血浆前激肽释放酶。关于其被活化因子XII激活以及被二异丙基氟磷酸酯灭活的研究。
Biochemistry. 1980 Mar 18;19(6):1151-60. doi: 10.1021/bi00547a018.
8
Immunochemical studies of plasma kallikrein.血浆激肽释放酶的免疫化学研究。
J Clin Invest. 1974 Dec;54(6):1444-54. doi: 10.1172/JCI107892.
9
An improved method of isolation of rat pancreatic prokallikrein. Characterization of the zymogen and of the kallikrein produced by trypsin activation.一种改进的大鼠胰腺激肽释放酶原分离方法。对该酶原及由胰蛋白酶激活产生的激肽释放酶的特性进行表征。
Biochim Biophys Acta. 1982 Oct 28;719(1):40-6. doi: 10.1016/0304-4165(82)90304-x.
10
Isolation and characterization of an inhibitor of factor XIIa from bovine plasma.
J Biol Chem. 1987 Sep 15;262(26):12714-21.

引用本文的文献

1
The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.蛋白聚糖在人血浆前激肽释放酶与细胞表面相互作用中的作用。
PLoS One. 2014 Mar 12;9(3):e91280. doi: 10.1371/journal.pone.0091280. eCollection 2014.
2
Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.化脓性链球菌从人血浆中吸收激肽原后会释放缓激肽。
Biochem J. 1997 Sep 15;326 ( Pt 3)(Pt 3):657-60.
3
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
重组α1-抗胰蛋白酶Ala357 Arg358对因子XII片段诱导的动脉低血压的保护作用。
J Clin Invest. 1987 Aug;80(2):582-5. doi: 10.1172/JCI113108.
4
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.当C1抑制剂的反应中心被血浆激肽释放酶、活化的因子XII片段、C1酯酶或中性粒细胞弹性蛋白酶切割时,会产生一种常见的新表位。
J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650.